These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19358983)

  • 1. Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors.
    Lucas JL; Mirshahpanah P; Haas-Stapleton E; Asadullah K; Zollner TM; Numerof RP
    Cell Immunol; 2009; 257(1-2):97-104. PubMed ID: 19358983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deacetylase inhibitor trichostatin A down-regulates Foxp3 expression and reduces CD4+CD25+ regulatory T cells.
    Liu Z; Zhang C; Sun J
    Biochem Biophys Res Commun; 2010 Sep; 400(3):409-12. PubMed ID: 20801101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effects of Artemisia princeps in antigen-stimulated T cells and regulatory T cells.
    Chang SH; Jung EJ; Park YH; Lim DG; Ko NY; Choi WS; Her E; Kim SH; Choi KD; Bae JH; Kim SH; Kang CD; Han DJ; Kim SC
    J Pharm Pharmacol; 2009 Aug; 61(8):1043-50. PubMed ID: 19703348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deacetylase inhibition promotes the generation and function of regulatory T cells.
    Tao R; de Zoeten EF; Ozkaynak E; Chen C; Wang L; Porrett PM; Li B; Turka LA; Olson EN; Greene MI; Wells AD; Hancock WW
    Nat Med; 2007 Nov; 13(11):1299-307. PubMed ID: 17922010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice.
    Reilly CM; Thomas M; Gogal R; Olgun S; Santo A; Sodhi R; Samy ET; Peng SL; Gilkeson GS; Mishra N
    J Autoimmun; 2008 Sep; 31(2):123-30. PubMed ID: 18650065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice.
    Kim TH; Jung JA; Kim GD; Jang AH; Cho JJ; Park YS; Park CS
    Int Immunopharmacol; 2010 Oct; 10(10):1310-5. PubMed ID: 20728595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors promote mice corneal allograft survival through alteration of CD4+ effector T cells and induction of Foxp3+ regulatory T cells.
    Guo X; Jie Y; Ren D; Zeng H; Zhang Y; He Y; Pan Z
    Cell Immunol; 2012; 277(1-2):8-13. PubMed ID: 22776176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
    Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling.
    Chung YL; Pui NN
    J Dermatol Sci; 2011 Dec; 64(3):163-73. PubMed ID: 21924869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma.
    Dalgard CL; Van Quill KR; O'Brien JM
    Clin Cancer Res; 2008 May; 14(10):3113-23. PubMed ID: 18483379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin application of ketoprofen systemically suppresses contact hypersensitivity by inducing CD4(+) CD25(+) regulatory T cells.
    Atarashi K; Mori T; Yoshiki R; Kabashima K; Kuma H; Tokura Y
    J Dermatol Sci; 2009 Mar; 53(3):216-21. PubMed ID: 19157794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: CD4-independent development of functional FoxP3+ regulatory T cells.
    Blache C; Adriouch S; Calbo S; Drouot L; Dulauroy S; Arnoult C; Le Corre S; Six A; Seman M; Boyer O
    J Immunol; 2009 Oct; 183(7):4182-6. PubMed ID: 19767568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
    Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory action of Cudrania tricuspidata on spleen cell and T lymphocyte proliferation.
    Chang SH; Jung EJ; Lim DG; Oyungerel B; Lim KI; Her E; Choi WS; Jun MH; Choi KD; Han DJ; Kim SC
    J Pharm Pharmacol; 2008 Sep; 60(9):1221-6. PubMed ID: 18718127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased numbers of thymic and peripheral CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling.
    Ordoñez-Rueda D; Lozano F; Sarukhan A; Raman C; Garcia-Zepeda EA; Soldevila G
    Eur J Immunol; 2009 Aug; 39(8):2233-47. PubMed ID: 19609976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors in cancer therapy.
    Fouladi M
    Cancer Invest; 2006; 24(5):521-7. PubMed ID: 16939962
    [No Abstract]   [Full Text] [Related]  

  • 20. FOXP3 ensembles in T-cell regulation.
    Li B; Samanta A; Song X; Furuuchi K; Iacono KT; Kennedy S; Katsumata M; Saouaf SJ; Greene MI
    Immunol Rev; 2006 Aug; 212():99-113. PubMed ID: 16903909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.